Ontology highlight
ABSTRACT: Background
This study aims to investigate EGFR as a prognostic biomarker in oropharyngeal squamous cell carcinoma (OPSCC).Methods
OPSCC patients from retrospective (1998-2009) and prospective cohorts (2014-2017) were included. Retrospectively collected tumors were used to construct tissue microarrays (TMAs), which were stained with EGFR, p16, DAPI and Pan-cytokeratin, and digitally quantified. EGFR, CDKN2A and HPV E6/7 levels from prospectively collected OPSCC was measured by droplet digital PCR (ddPCR). Biomarkers were compared to patient covariates, factors and survival outcomes.Results
A total of 249 patients were included retrospectively and 64 patients were enrolled prospectively. p16 status (p?ConclusionsTotal EGFR tumor levels are predictive of 5-year DSS. EGFR levels correlate with. smoking and could be an objective marker for this disease etiology.
SUBMITTER: Sivarajah S
PROVIDER: S-EPMC6327450 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Sivarajah Shanmugappiriya S Kostiuk Morris M Lindsay Cameron C Puttagunta Lakshmi L O'Connell Daniel A DA Harris Jeffrey J Seikaly Hadi H Biron Vincent L VL
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 20190110 1
<h4>Background</h4>This study aims to investigate EGFR as a prognostic biomarker in oropharyngeal squamous cell carcinoma (OPSCC).<h4>Methods</h4>OPSCC patients from retrospective (1998-2009) and prospective cohorts (2014-2017) were included. Retrospectively collected tumors were used to construct tissue microarrays (TMAs), which were stained with EGFR, p16, DAPI and Pan-cytokeratin, and digitally quantified. EGFR, CDKN2A and HPV E6/7 levels from prospectively collected OPSCC was measured by dro ...[more]